Atlas Trials

Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin

Clinical trial NCT00491179 · COMPLETED

Trial details

NCT number
NCT00491179
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis CHemodialysis
Start date
2006-06-01
Primary completion
2008-06-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.